Related Experiment Video
Updated: Mar 16, 2026

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics
Published on: July 16, 2018
Emerging technologies for protease engineering: New tools to clear out disease
Jennifer L Guerrero1, Patrick S Daugherty1, Michelle A O'Malley1
1Department of Chemical Engineering, University of California, Santa Barbara, California 93106.
Protease engineering advances enable novel therapeutic applications by improving enzyme selectivity and stability. New high-throughput methods allow for the redesign of proteases, expanding their therapeutic potential.
Area of Science:
- Biotechnology
- Biochemistry
- Enzymology
Background:
- Proteases are crucial enzymes regulating biological processes by cleaving proteins.
- Their broad substrate specificity poses challenges for therapeutic applications, limiting current use to a few proteases.
- Engineering protease selectivity, activity, and stability is essential for wider therapeutic use.
Purpose of the Study:
- To review recent advances in protease engineering tools and methods.
- To highlight opportunities for redesigning human secreted proteases.
- To discuss the future potential of engineered proteases in therapeutics.
Main Methods:
- Development of high-throughput bacterial and yeast-based screening methods.
- Protease redesign focusing on specificity, activity, and stability.
- Engineering of human secreted proteases.
Main Results:
- Protease variants with novel specificities have been generated.
- Engineered proteases exhibit reduced toxicity and increased resistance to inhibitors.
- New tools facilitate the redesign of human secreted proteases.
Conclusions:
- Protease engineering offers significant potential for biotechnological and therapeutic applications.
- Advances in high-throughput methods are key to overcoming limitations of current protease therapeutics.
- Further development of protease engineering tools will expand their use in medicine.
More Related Videos
19:23Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation
Published on: January 16, 2019
05:08Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Recombinant DNA
CRISPR
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...